Bulletin
Investor Alert

New York Markets Open in:

press release

April 4, 2022, 4:15 p.m. EDT

IFF Completes Acquisition of Health Wright Products

NEW YORK, (BUSINESS WIRE) -- IFF /zigman2/quotes/206698429/composite IFF -1.87% today announced that it has completed the previously announced acquisition of Health Wright Products, LLC (HWP), a leader in formulation and capsule manufacturing for the dietary supplement industry and a long-time business partner of IFF’s Health & Biosciences probiotics business.

HWP is known in the consumer Health and Nutrition industries for providing the highest-quality nutritional supplements. Using state-of-the-art processes and equipment, HWP manufactures custom formulations and delivers encapsulation and packaging to meet the industries’ exacting requirements for probiotic products. Under IFF’s leadership, HWP will continue to invest in capacity and expand capabilities to meet the evolving needs of customers and consumers.

Health Wright Products employs over 225 people, all of whom will continue with the company after the sale. Financial terms of the deal have not been disclosed.

Cautionary Statement under the Private Securities Litigation Reform Act of 1995

This press release contains “forward-looking statement” within the meaning of the federal securities laws, including Section 27A of the Securities Act, and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Forward-looking statements often address expected future business and financial performance and financial condition, and often contain words such as “expect,” “anticipate,” “intend,” “plan,” “believe,” “seek,” “see,” “will,” “would,” “target,” similar expressions, and variations or negatives of these words. Forward-looking statements by their nature address matters that are, to different degrees, uncertain, such as statements about the proposed transaction and the expected timetable for completing the proposed transaction. The forward-looking statements included in this release are made only as of the date hereof, and we undertake no obligation to update the forward-looking statement to reflect subsequent events or circumstances.

About Health Wright Products, LLC.

At Health Wright Products, a contract manufacture of dietary supplements, Quality, Service and Value have been the driving principles in our commitment to exceeding customers’ expectations. We partner with brands committed to the same driving principles for themselves and their customers. As an industry leader, we leverage innovation, technology, experience and capacity to offer better solutions to current and emerging products. Providing better health by Encapsulating Excellence. Learn more at healthwrightproducts.com

About IFF’s Health & Biosciences division

Inspired by nature and distinguished by its world-class bioscience and microbiome capabilities, IFF’s Health & Biosciences division is a leading innovation partner for customers across a broad range of consumer product, industrial and agricultural sectors. IFF’s Health & Biosciences division works closely with our customers to enhance products – and their processes – to deliver safer, healthier and more sustainable solutions.

Welcome to IFF

At IFF /zigman2/quotes/206698429/composite IFF -1.87% , an industry leader in food, beverage, health, biosciences and scent, science and creativity meet to create essential solutions for a better world – from global icons to unexpected innovations and experiences. With the beauty of art and the precision of science, we are an international collective of thinkers who partners with customers to bring scents, tastes, experiences, ingredients and solutions for products the world craves. Together, we will do more good for people and planet. Learn more at iff.com , Twitter , Facebook , Instagram , and LinkedIn .

© 2022 by International Flavors & Fragrances Inc. IFF is a Registered Trademark. All Rights Reserved.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220404005789/en/

SOURCE: IFF

Michael DeVeau
Chief Investor Relations & Communications Officer
+1.212.708.7164
Michael.DeVeau@iff.com

COMTEX_405227295/2456/2022-04-04T16:15:29

Is there a problem with this press release? Contact the source provider Comtex at editorial@comtex.com. You can also contact MarketWatch Customer Service via our Customer Center.

Copyright Business Wire 2022

/zigman2/quotes/206698429/composite
US : U.S.: NYSE
$ 119.14
-2.27 -1.87%
Volume: 1.19M
June 27, 2022 4:00p
P/E Ratio
54.74
Dividend Yield
2.65%
Market Cap
$30.94 billion
Rev. per Employee
$485,667
loading...
/zigman2/quotes/206698429/composite
US : U.S.: NYSE
$ 119.14
-2.27 -1.87%
Volume: 1.19M
June 27, 2022 4:00p
P/E Ratio
54.74
Dividend Yield
2.65%
Market Cap
$30.94 billion
Rev. per Employee
$485,667
loading...

Comtex

Partner Center

Link to MarketWatch's Slice.